IL32 and Arthritis: In this article, we describe a variety of approaches used for modulation of cytokine responses to control arthritis (Figure 2, Table 1 and Table 2) and the properties of relatively newer cytokines (IL-32, IL-34, and IL-35), which have shown association with RA pathology and are being tested for their use in arthritis therapy in experimental models of RA.